SCHEMBL5827434

SCHEMBL5827434

COC1=Nc2ccccc2CC1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
ALDH1A1 P00352 5/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
BCHE P06276 1/20 0.37
CES1 P23141 1/20 0.37
HRH4 Q9H3N8 1/20 0.36
TRPA1 O75762 4/20 0.36
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
KDM4E B2RXH2 4/20 0.35
MAPT P10636 3/20 0.35
GAA P10253 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP1A2 P05177 1/20 0.34
HPGD P15428 1/20 0.34
SIGMAR1 Q99720 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9958235 0.77 BCHE (0.37) NOS3NOS1NOS2ALDH1A1BCHE
SCHEMBL7264315 0.77 METAP1 (0.35) ALDH1A1PDE3BPDE3AGAAMEN1
SCHEMBL8177168 0.76 NOS3 (0.42) NOS3NOS1NOS2ALDH1A1NPC1
SCHEMBL2778638 0.73 TRPA1 (0.48) NOS3NOS1NOS2ALDH1A1NPC1
SCHEMBL9255866 0.73 NPC1 (0.41) NOS3NOS1NOS2ALDH1A1NPC1
SCHEMBL3626217 0.72 NOS3 (0.52) NOS3NOS1NOS2ALDH1A1NPC1
SCHEMBL4145325 0.72 NOS3 (0.42) NOS3NOS1NOS2ALDH1A1NPC1
SCHEMBL9674946 0.72 NOS3 (0.42) NOS3NOS1NOS2ALDH1A1NPC1
SCHEMBL729365 0.70 NOS3 (0.41) NOS3NOS1NOS2ALDH1A1NPC1
SCHEMBL11371357 0.70 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2TRPA1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4228624-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 Therapeutics, Inc. (US) 2023-08-23 EP disclosed
WO-2022081927-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed
EP-1660497-A1 [ 1,8]NAPHTHYRIDIN-2-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA Warner-Lambert Company LLC (US) 2006-05-31 EP disclosed
WO-2005019215-A1 [1,8]NAPHTHYRIDIN-2-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA WARNER-LAMBERT COMPANY LLC (US) 2005-03-03 WO disclosed